Dingxin Capital

Dingxin Capital is an investment management agency established in 2014 and headquartered in Shenzhen, China. The firm specializes in equity investments, particularly within the healthcare and TMT (Technology, Media, and Telecommunications) sectors. Its partners bring extensive experience from leading domestic investment institutions, which enhances the firm's capabilities in the equity investment field. Dingxin Capital emphasizes the importance of organizational development to create a sustainable competitive advantage in the investment landscape.

Hu Hui

Founding Partner

Deng Ning

Partner

Zhou Zhou

Senior Partner

36 past transactions

Novlead Biotech

Series C in 2025
Novlead Biotech is a company dedicated to enhancing human health through innovative medical technologies. It specializes in the development and manufacturing of medical devices that target cardiopulmonary, respiratory, and anti-infection applications. The company's primary focus is on the medical use of nitric oxide to address conditions such as pulmonary hypertension and infectious diseases. By leveraging its technological advancements, Novlead Biotech aims to improve treatment efficiency in hospitals and enhance the quality of life for patients.

Fine Vision

Series A in 2025
Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's Wuhan Optoelectronics National Research Center under the Huazhong Technology Technology transition.

Zhihe Biotechnology

Seed Round in 2024
Zhihe Bio is a synthetic biology manufacturer of oleochemicals.

Reju Therapeutics

Seed Round in 2024
Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions.

Ruining Bio

Series B in 2024
Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.

Legendsemi

Series A in 2023
Legendsemi is a company dedicated to the development and design of high-performance analog and mixed-signal chips. It specializes in creating mid-to-high-end digital-analog hybrid products, focusing on the research and development of semiconductor solutions that primarily involve high-precision signal chains and signal chain microcontrollers or system-on-chips. Through its innovative approach, Legendsemi aims to deliver advanced technology that meets the demands of modern electronic applications.

Sitrus Technology

Series C in 2023
Sitrus Technology is a company founded by professionals returning from overseas, focused on developing and manufacturing high-speed network connectivity processors. The company specializes in producing high-speed optical module digital signal processor (DSP) chips, which are essential components in the semiconductor industry. These chips incorporate advanced high-end analog and mixed-signal circuits, enabling module manufacturers to enhance efficiency and reduce costs. Sitrus Technology's innovations support a range of applications across various industries, including cloud computing, the Internet of Things, big data, 5G connectivity, intelligent manufacturing, and artificial intelligence networks, positioning the company as a key player in the high-speed optical communication sector.

Ai Ma Biology

Angel Round in 2023
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.

Semitech

Series C in 2023
Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.

Vivest

Series B in 2022
Vivest engages in R&D of emergency medical equipment.

Longsailing

Seed Round in 2022
Longsailing is a semiconductor manufacturing firm that works on smart connectivity and wireless sectors.

DHC Medical

Series A in 2022
DHC Medical is an assisted reproductive service provider

Future Meijia

Angel Round in 2022
Future Meijia is a digital system based on the area of interior design. It can enable businesses to open up links such as design, contract signing, payment, product selection, building, and delivery, and promote businesses and employees. Traditional decoration companies, whole-house customization businesses, and enterprises can all benefit from this.

Resnics

Series A in 2022
Resnics specializes in the manufacture of storage and network data processor chip solutions tailored for the communications and Internet sectors. The company boasts a technical team comprised of experienced professionals and research and development personnel with expertise in networking, storage, and systems. This deep technical proficiency extends to areas such as networking, switching, storage, and high-performance CPUs. Resnics is committed to becoming a high-tech innovation leader, aiming to meet the increasing demands of data centers for advanced chip technology.

IMPACT Therapeutics

Series D in 2022
IMPACT Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics for cancer and other life-threatening diseases. Founded in 2009 and based in Shanghai, China, the company focuses on creating targeted anti-cancer treatments utilizing synthetic lethality. IMPACT Therapeutics is actively engaged in several research and development projects, including a PARP inhibitor, a Wee1 inhibitor, and various novel agents targeting DNA damage response mechanisms and the Hedgehog signaling pathway. Through its commitment to advancing treatment options, IMPACT Therapeutics aims to provide patients with effective and targeted anti-cancer therapies.

Resnics

Seed Round in 2021
Resnics specializes in the manufacture of storage and network data processor chip solutions tailored for the communications and Internet sectors. The company boasts a technical team comprised of experienced professionals and research and development personnel with expertise in networking, storage, and systems. This deep technical proficiency extends to areas such as networking, switching, storage, and high-performance CPUs. Resnics is committed to becoming a high-tech innovation leader, aiming to meet the increasing demands of data centers for advanced chip technology.

Tongee Medical Technology

Venture Round in 2021
Tongee Medical Technology specializes in the development and manufacturing of innovative medical devices aimed at treating metabolic diseases, including obesity, type 2 diabetes, and nonalcoholic fatty liver disease. The company focuses on creating stent medical devices, with notable products such as a gastric bypass stent system and other related stent devices. These products are designed to provide relief for patients suffering from various metabolic conditions, enhancing their quality of life through advanced medical solutions.

Zhongtian Medical Device Technology

Venture Round in 2021
Zhongtian Medical Device Technology focuses on interventional medical devices for cerebrovascular neurosurgery. The products include acute ischemia treatment products, chronic ischemia treatment products, and access products.

Zhixin Semiconductor

Seed Round in 2021
Zhixin Semiconductor manufactures high-reliability controllers and processor chips for automotive systems.

Petabyte

Venture Round in 2021
Petabyte is a technology company specializing in the design and manufacture of advanced memory chips. Their products feature high endurance non-volatile flash memory, enabling them to bridge the gap between traditional DRAM and Flash memory. These chips offer increased storage density, high speeds, low power consumption, and cost-effectiveness, catering primarily to embedded systems and IoT applications.

Mindsemi

Series B in 2020
Mindsemi is a company that designs and manufactures optoelectronic semiconductor chips. It specializes in a comprehensive range of optical chips tailored for lasers, detectors, and packaging. By providing high-quality products, Mindsemi supports global optical component and module manufacturers, enhancing their capabilities in optical communication. The company offers a diverse lineup of chips, including those for 2.5G, 10G, 25G, and 50G applications.

Zettasensing

Venture Round in 2020
Zettasensing is an integrated circuit company that focuses on the R&D and application of mid-to-high-end sensor chips. The company is based in Jingxi Zhongguancun Mentougou Science and Technology Park.

360

Venture Round in 2020
360 is an internet and security service company that creates 360 Security Guard, 360 Mobile Guard, 360 Security Browser, and other security solutions. 360 is headquartered in Beijing, China and was founded in 2017.

etailor

Series A in 2019
Etailor is an online clothing brand specializing in European and American fit wear, known for its commitment to quality and customization. Based in Guangzhou, a hub of the domestic apparel industry, the company operates several stores and central garment factories in major cities such as Beijing, Shanghai, and Shenzhen. With a team of seasoned tailors and fashion designers boasting over 20 years of experience, Etailor offers a comprehensive tailoring service that includes free door-to-door pick-up and a 30-day unconditional repair policy. The company has innovated the traditional tailoring process by implementing a centralized factory and utilizing enterprise resource planning (ERP) data management. This technological integration connects tailor service providers with consumers, streamlining access to personalized clothing alterations and enhancing the overall customer experience.

Jifu Medical

Series B in 2019
Jifu Medical is a national high-tech enterprise dedicated to the research, development, production, and sales of advanced medical products specifically for the digestive tract. With a strong emphasis on innovation, the company has established a professional research and development team and an international management platform, leading to the completion of numerous national technological innovation projects and the acquisition of over 100 national patents. Jifu Medical's flagship product line, the "Dasheng" magnetically controlled capsule endoscope system, has been under development for a decade and has received both National Medical Products Administration Class III registration and EU CE certification. These innovations have earned widespread acclaim from medical institutions, particularly for their application in non-invasive intestinal examinations, enhancing diagnostic capabilities for healthcare practitioners.

Farmove Medical

Venture Round in 2019
Farmove Medical is a company focused on the development and technical consultation of medical device technologies, particularly for the monitoring and early detection of chronic diseases affecting the cardiac, nervous, endocrine systems, and hypertension. Additionally, the company specializes in the research and development of innovative solutions for spinal diseases, including self-locking and absorbable cervical fusion cage technologies designed for cervical spine treatment. By providing essential medical equipment and expertise, Farmove Medical aims to enhance healthcare outcomes in the management of chronic and spinal conditions.

Antaike Medical

Series A in 2018
Antaike Medical is a minimally invasive interventional medical equipment supplier.

E-SellTech

Seed Round in 2018
E-SellTech offers a platform that connects offline electronic screens, advertisers, and advertising audiences through the internet and internet of things technology. It provides management services for media owners and transforms traditional media through IOT and SAAS.

NepQD

Seed Round in 2018
NepQD is a biological product company located in Jiangsu, specializing in the development and manufacturing of diagnostic devices and products. The company focuses on utilizing high fluorescence efficiency and biocompatible quantum dot materials as its core patented technology. This innovative approach enhances the sensitivity and accuracy of its diagnostic devices, positioning NepQD as a key player in the field of medical diagnostics. Through its commitment to advancing diagnostic capabilities, NepQD aims to contribute significantly to healthcare solutions.

Arigin Medical

Series A in 2017
Arigin Medical is a private company based in Shanghai, China, specializing in medical three-dimensional solutions. Founded in 2014, the company focuses on 3D printing technology specifically for orthopedic applications. Arigin Medical develops surgical guides and orthopedic splints that aim to enhance surgical procedures for knee and other lower body operations. By leveraging innovative 3D printing techniques, the company seeks to improve treatment outcomes for healthcare professionals and their patients.

Haoshou Bang

Series A in 2017
Haoshou Bang provides hotel employment management systems.

GrowingUP

Angel Round in 2017
GrowingUP is an animator's studio operator. For both children and adults, the company creates movies, video games, virtual worlds, web apps, and mobile/iPod entertainment. The business produces, advertises, and broadcasts animated programs and films so that viewers can experience motion graphics and mixed media.

Jifu Medical

Series A in 2017
Jifu Medical is a national high-tech enterprise dedicated to the research, development, production, and sales of advanced medical products specifically for the digestive tract. With a strong emphasis on innovation, the company has established a professional research and development team and an international management platform, leading to the completion of numerous national technological innovation projects and the acquisition of over 100 national patents. Jifu Medical's flagship product line, the "Dasheng" magnetically controlled capsule endoscope system, has been under development for a decade and has received both National Medical Products Administration Class III registration and EU CE certification. These innovations have earned widespread acclaim from medical institutions, particularly for their application in non-invasive intestinal examinations, enhancing diagnostic capabilities for healthcare practitioners.

Biosis Healing

Series B in 2016
Biosis Healing specializes in regenerative medicine materials and implantable medical devices tailored for clinical surgery. The company offers a range of innovative products designed for minimally invasive procedures, including solutions for hernia repair, abdominal wall surgery, dentistry, and neurosurgery. Among its notable offerings are regenerative surgical bio-materials and implantable soft tissue repair mesh, which assist in the regeneration of tissue defects. One of its key developments is a non-crosslinked Extracellular Matrix bio-material that promotes tissue repair and functional regeneration following surgical resections. Biosis Healing is committed to advancing technology and treatment approaches through collaboration with clinical specialists, continually working to enhance its product lineup and improve surgical outcomes.

Giant Network

Venture Round in 2016
Giant Network, established in 2004, is a Shanghai-based company specializing in the development and operation of massively multiplayer online role-playing games (MMORPGs). It offers approximately 13 games, predominantly MMORPGs, with a few casual and strategy web games, all primarily operating on a free-to-play model with in-game purchases. Notable titles include ZT Online, King of Kings III, and Giant Online. The company distributes its games through regional distributors and its official game website.

Focus Media

Series D in 2004
Focus Media Holding Limited is a prominent digital media company based in Central, Hong Kong, specializing in out-of-home advertising through a diverse array of platforms. The company operates an extensive network of liquid crystal display (LCD) screens and other advertising formats strategically located in high-traffic areas, including malls, hotels, and residential buildings. Its offerings encompass video media in commercial buildings, digital displays in stores, advertising in elevators, and large outdoor LED screens, as well as traditional billboards and cinema advertising. With a significant presence across approximately 112 cities in China, Focus Media has established a vast network that includes over 172,000 digital displays, more than 505,000 traditional poster frames, and extensive cinema partnerships. The company is known for its innovative business models and targeted audience segmentation, making it a key player in the media advertising industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.